Importantly, patients with PBC and PSC who receive a combination treatment with UDCA and fenofibrate show significantly reduced elevated levels of serum total bilirubin levels [14], suggesting that the activation of PPARα may reduce bilirubin levels through UGT1A1 enzyme activation. Here, PPARA is linked to primary biliary cholangitis.